Belgium · Medical and donor conditions

Medical consent review desk with microscope, records and sample trays

Belgium surrogacy: medical and donor requirements

Legal framework and the decision that matters

Belgium has no dedicated, comprehensive surrogacy law. That does not mean that every surrogacy arrangement is authorized or that a clinic must accept one. When assisted reproductive techniques, donor gametes or stored embryos are involved, the Act of 6 July 2007 and professional safety rules matter. A clinical decision and the later legal status of a child are separate questions. This guide concerns the medical and donor conditions, not a full analysis of contracts, parentage, nationality or travel.

The practical starting point is to distinguish three levels: binding legislation for assisted reproduction; medical safety standards and professional duties; and each fertility centre’s surrogacy acceptance policy. A clinic’s requirement for a documented medical indication, a genetic connection or a multidisciplinary assessment may be decisive for that clinic without being a universal Belgian statutory eligibility test. A favourable clinic decision does not settle the subsequent parentage process.

Age and medical assessment

Article 4 of the consolidated Act permits egg retrieval and submission of a request for embryo transfer or insemination for an adult woman until the day before her 46th birthday. The transfer or insemination itself can take place until the day before her 48th birthday. These are distinct stages, not a blanket right to a surrogacy procedure. Identify the person undergoing each intervention; do not automatically transfer these limits to an intended father or treat them as a complete rule about surrogates.

An exception allows retrieval for cryopreservation of gametes, surplus embryos or gonadal material from a minor where medically indicated. It does not allow ordinary insemination or surrogacy treatment of minors. Earlier, unamended versions of the 2007 text display different age wording; use the amended provision effective 6 January 2017 rather than those historical figures.

IVF and cryopreservation of the covered reproductive material must take place in authorised fertility centres. Where relevant, the centre checks infertility or subfertility assessment, provides fair information about the procedures and offers psychological counselling before and during treatment. In a surrogacy proposal, expect separate clinical assessment of the person carrying the pregnancy, embryo or gamete sources and the prospective parents; the exact screening list must be requested from the treating team.

Consent, gametes and donor safeguards

Before medically assisted reproduction, Article 7 requires an agreement between the centre and the person or persons pursuing the parental project. It records identity, age, address and centre details; where the applicants form a couple, both sign. This clinical agreement is not proof that a private surrogacy undertaking will be enforceable or that parental status will transfer after birth. Ask the centre which consents relate to retrieval, storage, donation, embryo transfer and any later change of instructions.

Gamete donation must be gratuitous: the sale of human gametes is prohibited. The Act permits defined compensation for certain expenses or losses subject to applicable rules, not a market price for eggs or sperm. Donations designed for eugenic selection or nonmedical sex selection are prohibited; matching donors and recipients is expressly distinguished from eugenic selection. Combining gametes from different donors in simultaneous insemination is prohibited. These rules also matter when a surrogacy plan uses a donor.

Under Article 55, gametes from one donor may not result in births to more than six different women; this is not a six-child cap. Special counting language applies where two women jointly pursue a parental project. Imported donor material requires additional verification within the regulated chain. In 2025 the medicines agency reported actual breaches of the limit. Ask the centre how it checks donor identity, medical safety, traceability and the six-women rule rather than relying on a donor-bank advertisement.

Since September 2023, amended Article 55 requires centres to use an inter-centre database when checking the six-women donor limit. For gametes brought in from abroad, the receiving centre must also request assurances from the supplier that supplying that donor’s material will not breach the Belgian limit and that it will not be supplied beyond the permitted number of Belgian recipients. This is a duty of the centre, not a self-certification by the intended parents. Ask the centre to document its traceability and quota checks before import or transfer; a foreign donor bank’s catalogue is insufficient.

Anonymity, embryo and clinic policy

The consolidated Act provides an anonymity default for gamete programmes but permits identified donation by agreement between donor and recipient. A June 2026 government announcement approved a draft to abolish anonymity more broadly, yet described it as a bill still undergoing the legislative process. Its enactment and effective provisions were not established for this guide. Obtain the current Belgian Official Gazette text and the centre’s written explanation before promising anonymity or a future right of access to donor identity. An important qualification: judgment 102/2024 of Belgium’s Constitutional Court, delivered on 26 September 2024, found the absolute refusal to give a donor-conceived child any identifying or non-identifying donor information unconstitutional. The Court nevertheless maintained the effects of the affected provisions until replacement legislation enters into force, and no later than 30 June 2027 inclusive. That judgment does not prove the 2026 bill has entered into force.

Surplus-embryo donation and storage have their own statutory consent and allocation provisions; do not assume that donated eggs, donated sperm and donated embryos follow identical instructions. Preimplantation genetic testing for eugenic selection or ordinary sex selection is prohibited, with a limited exception concerning avoidance of sex-linked disease; special therapeutic circumstances require separate assessment. Neither a donor arrangement nor a laboratory result bypasses the receiving centre’s safety and informed-consent obligations.

Articles 22 and 26 treat surplus-embryo donation separately: the consolidated law describes it as gratuitous and anonymous, and embryos from one donor or donor couple may not result in births to more than six different women. Imported embryos also require the centre to obtain supplier assurances about the Belgian limit. By contrast, Article 57 expressly permits non-anonymous gamete donation agreed between the donor and recipient. As the 2026 legislative proposal addresses both gamete and embryo anonymity, verify any enacted changes and transitional rules before selecting material. The wording of an old consent form is not conclusive.

UZ Gent illustrates the distinction between law and policy. Its high-technology surrogacy pathway describes use of genetic material from at least one intended parent, a legal consultation at the assessment stage and a multidisciplinary decision before treatment. The clinic reports considering some different family configurations, but those facts are not a nationwide entitlement or promise of admission. Its separate age chart marks certain egg-donor cut-offs as centre-defined, rather than statutory.

Age rules must be linked to a particular person and treatment. UZ Gent’s published chart lists transfer to a gestational carrier until the day before her 45th birthday, whereas Article 4 describes a general upper limit of the day before 48 for transfer or insemination in an adult woman and an earlier deadline to request treatment. The centre’s surrogacy-specific figure must not be presented as a nationwide statutory cut-off without identifying its legal basis. Ask whether it reflects its protocol, its interpretation or another binding requirement. Check separately the ages and medical eligibility of the egg donor, sperm provider, gestational carrier and any intended mother undergoing treatment.

Rule-versus-policy decision matrix

RequirementLegal rule or clinic policy
Age for retrieval or initial requestBinding Act: adult woman before 46; this is not a general surrogacy permit.
Donor and screening conditionsBinding law regulates unpaid donations, safety and quotas; centre adds documented clinical criteria.
Centre admission to surrogacyIndividual medical and ethical review; no uniform mandatory Belgian surrogacy admission list.

Documents, refusal and next actions

Before committing to treatment, send the centre a written case outline identifying the intended parent(s), proposed gestational carrier, genetic contributors, known or bank donor, and where samples or embryos are stored. Request the medical indication and required records; donor screening and traceability documents; storage and transfer consents; treatment protocol, age assessment and written fee explanation. Ask which rules are statutory and which are centre policies, and seek independent legal advice on the separate parentage issue.

Use four decision checkpoints before authorising any transfer: identify every participant, their age and reproductive role; obtain the centre’s written surrogacy criteria, donor-origin records, screening and import requirements; confirm whose written consents are required for retrieval, storage, donation and transfer and how instructions can be changed; and commission separate advice on legal parentage before a pregnancy is attempted. This is a practical document checklist, not a uniform Belgian statutory application form. Ask for a written explanation if the proposed combination of carrier, donor material and intended parents cannot be accepted. Clinical approval, treatment funding and later recognition of parentage are different decisions.

For insemination using donated gametes, Article 61 requires the recipient to send a request to the centre by registered letter, signed by both applicants when they are a couple. The centre must respond within two months after the letter is sent. Do not extend this specific statutory procedure to every IVF or surrogacy arrangement: ask whether it covers the proposed treatment and retain sending and response records.

If a centre declines an assisted reproduction request, Article 5 provides written notice within one month of the physician’s decision. The refusal must mention medical reasons or the conscience clause; if requested, it must supply details of another centre. This does not create an appeal guaranteeing surrogacy admission. Preserve correspondence, ask what evidence or criteria were decisive, and consider another accredited centre or professional legal assessment before taking irreversible steps.

Example: a proposed surrogate is medically assessed while donor eggs would come from a bank abroad. The team must distinguish the woman receiving transfer from the egg donor, verify the treatment-stage age limits, review donor safety and the six-women cap, and decide whether its own surrogacy protocol accepts the arrangement. Even a medically accepted embryo transfer leaves legal parentage to be analysed separately. Do not order gametes or sign commitments before this sequence is confirmed.

Bottom line: Belgian assisted-reproduction legislation sets real thresholds, prohibitions and consent duties, but does not supply a nationwide surrogacy eligibility certificate. Obtain a centre-specific written decision, verify the up-to-date donor legal regime and obtain separate advice on parental status. This article records the sources; later statutory changes, especially donor anonymity, require confirmation before action.

Primary materials

  1. Consolidated Belgian Act of 6 July 2007, amendments through 17 May 2024 (S01)
  2. Belgian Institute for the Equality of Women and Men, 2026 recommendation on surrogacy (S02)
  3. UZ Gent: Donation and surrogacy (S03)
  4. UZ Gent legal and centre-specific age limits (S04)
  5. Belgian Council of Ministers, donor anonymity draft in second reading, 20 June 2026 (S05)
  6. FAMHP, donor quota breach report, 6 June 2025 (S06)
  7. Bioethics Advisory Committee opinion 86, 2023 (S07)
  8. Belgian Constitutional Court, judgment 102/2024 of 26 September 2024 (donor information; preserved effects to 30 June 2027) (S08)

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards